-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $13

Benzinga·05/14/2025 17:48:12
Listen to the news
Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $12 to $13.